Recently, under the strong leadership of the Lixin County Party Committee and government, the Lixin County Health Commission led a joint initiative involving Lixin County People's Hospital, Lixin County Traditional Chinese Medicine Hospital, Lixin County Second People's Hospital, Lixin County Maternal and Child Health Care Hospital, Lixin County Center for Disease Control and Prevention, and other medical consortium units to collaborate with GENOMBIO Life Health Holding Group (hereinafter referred to as "GENOMBIO") in establishing the Lixin County People's Hospital-GENOMBIO Clinical Research Center. This initiative marks a significant step for Lixin County to enhance its medical science and technology innovation capabilities and public health service levels, injecting new momentum into the high-quality development of the regional health industry.
The Clinical Research Center is located in the comprehensive R&D building of the GENOMBIO Life Health Industrial Park, with a planned area of 3,000 square meters. It is equipped to conduct research in clinical pathology, cellular biology, molecular biology, gene sequencing, and gene editing. Leveraging GENOMBIO's technical expertise in life sciences and innovation, the center will provide robust support for multi-level medical research and clinical diagnosis and treatment across Lixin County's medical consortium units, comprehensively meeting their practical needs in basic research and novel medical technology translation.
This collaboration, guided by the principles of "resource sharing, collaborative innovation, and service to the public's health needs," integrates resources from medical institutions and enterprises. By establishing a high-standard clinical research platform, the center will advance basic research and clinical applications in cutting-edge fields such as cell and gene therapies and cellular pharmaceuticals, accelerating the transformation and promotion of medical scientific achievements. The center's establishment will also enhance medical talent development and discipline construction, strengthening the research capabilities and service quality of the medical consortium to deliver more precise and high-quality healthcare to local residents.
As national healthcare reforms and the Healthy China strategy continue to progress, the establishment of Lixin County's Clinical Research Center aligns with the trend of coordinated development in medical innovation and the health industry. Through multi-party collaboration between government, medical institutions, and enterprises, the center not only promotes regional medical coordination but also opens new pathways for local economic and healthcare development. It serves as a model for related enterprises and medical institutions to actively participate in the national health system construction.
Looking ahead, GENOMBIO will leverage its technological innovation and clinical translation advantages in cell and gene therapies to deepen industry-academia-research collaboration with Lixin County's medical consortium members through the Clinical Research Center. This effort will drive health industry innovation, accelerate the implementation of scientific achievements, continuously improve public health outcomes, and contribute to the Healthy China strategy and the high-quality development of regional medical and health industries.